SecBot SecBot

ZTS

Zoetis Inc.
NYSE· Pharmaceutical Preparations· CIK 0001555280 Biotech & Drug Discovery
$83.74 −0.08 (−0.10%)
Nov 16 4:00 PM ET · prev $83.82
Market cap
$33.7B
Large cap
Consensus
Hold
41% Buy or better · 22 analysts
Median target
$85.00
+2% · range $73.00–115.00
1 year
−29.5%
from $118.80 · Nov 17
30 days
+5.5%
from $79.38
52-week range
$69.10–131.10
−36% from high · low Oct 1
Avg volume 20D
4.48M
shares / day
Short interest
16.72M
≈4.1% of shares · −4.5%
Days to cover
4.8
at average volume
Insider net
+$886.4K
3 buyers · 0 sellers · since Mar 27
New fund stakes
7
Q2 2026 13F · 2 exits
Reddit crowd
50°
Neutral · 4 mentions this week
SecBot read MIXED 4 reports · 90 days
Balance 1 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/4

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • May 1 to May 15 ▲ 2 buys: Ro Khanna bought $1,001 - $15,000, last disclosed Jun 11
  • May 11 to May 13 ▲ 2 days of insider buys: $886.4K by 3 insiders, avg $76.08
  • Jun 9 to Jun 16 ▲ 2 buys: Byron Donalds, Chuck Fleischmann and 1 more bought, last disclosed Jul 16
  • Jun 30 ▲ 7 funds open new positions (13F)
  • Jul 7 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Aug 12
  • Jul 17 to Jul 20 ▼ 2 sells: Gilbert Cisneros, Ro Khanna sold $1,001 - $15,000, last disclosed Sep 7
  • Aug 6 ▼ Zoetis reported Q2 2026 adjusted EPS of $1.87, a 1% beat vs. $1.85 c…
  • Sep 4 to Sep 18 ▲ 2 buys: Ro Khanna, Gilbert Cisneros bought $1,001 - $15,000, last disclosed Oct 13
  • Sep 11 to Oct 21 ▼ 4 sells: Ro Khanna, Shelley Moore Capito sold $1,001 - $15,000, last disclosed Nov 9
  • Oct 13 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Nov 9
  • Oct 20 ▼ Jefferies downgrades
  • Nov 5 ▲ Earnings: ZTS Q3 2026 Earnings: EPS $1.75 (+14.6% vs est)

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $886.4K at an average $76.08. No open-market sales. Price is 10% above their cost.

  • InstitutionsMIXED

    Q2 2026: 78 added (7 new), 91 trimmed or exited. Largest new: Flossbach Von Storch Se $302.6M, Qube Research & Technologies $163.8M.

  • AnalystsMIXED

    9 of 22 rate it Buy or better. Median target $85.00 (+2%).

  • Short sellersSTEADY

    Short interest −4.5% to 16.72M shares. 4.8 days to cover, ≈4.1% of shares.

  • TrendUPTREND

    10% above its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 4 mentions: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q2 2026
7
new positions
2
exits
$645.1M
in new stakes · top 4 shown
FundMoveSharesValue
MORGAN STANLEYTRIM8,878,849$638.0M
FLOSSBACH VON STORCH SENEW4,210,978$302.6M
AmundiADD3,988,618$286.6M
UBS Group AGADD3,643,241$261.8M
CITADEL ADVISORS LLCDOUBLED3,188,263$229.1M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD3,137,442$225.5M
VOLORIDGE INVESTMENT MANAGEMENT, LLCDOUBLED2,416,056$173.6M
BARCLAYS PLCADD2,302,737$165.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

22 analysts
Hold 41% rate it Buy or better
Strong Buy1Buy8Hold13Sell0Strong Sell0
12-month targets · 13 analysts

Price is inside the target range. Median implies +2%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 29, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Oct 27, 2026UBS
MAINTAIN
MAINTAINNeutral
Oct 20, 2026Jefferies
DOWNGRADE
DOWNGRADEHold
Oct 16, 2026Goldman Sachs
INITIATE
INITIATENeutral
Aug 25, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Aug 20, 2026Stifel
MAINTAIN
MAINTAINHold
Congressional trades
ZTS trades disclosed by members of Congress, with disclosure delay.
5 members · 10 buys / 8 sells
DateMemberType AmountDisclosed
Oct 21, 2026 Shelley Moore CapitoRSenate Spouse account · Zoetis Inc SELL $1K–$15K Nov 4, 2026 +14d
Oct 13, 2026 Ro KhannaDHouse Child account · Zoetis Inc BUY $1K–$15K Nov 5, 2026 +23d
Oct 7, 2026 Ro KhannaDHouse Spouse account · Zoetis Inc SELL $1K–$15K Nov 5, 2026 +29d
Sep 25, 2026 Ro KhannaDHouse Spouse account · Zoetis Inc SELL $1K–$15K Oct 7, 2026 +12d
Sep 18, 2026 Gilbert CisnerosDHouse Zoetis Inc BUY $1K–$15K Oct 12, 2026 +24d
Sep 11, 2026 Ro KhannaDHouse Child account · Zoetis Inc SELL $1K–$15K Oct 7, 2026 +26d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Zoetis Inc BUY $1K–$15K Oct 7, 2026 +33d
Jul 20, 2026 Ro KhannaDHouse Spouse account · Zoetis Inc SELL $1K–$15K Aug 7, 2026 +18d
Jul 17, 2026 Gilbert CisnerosDHouse Zoetis Inc SELL $1K–$15K Sep 4, 2026 +49d
Jul 7, 2026 Ro KhannaDHouse Child account · Zoetis Inc BUY $1K–$15K Aug 7, 2026 +31d

Insider ledger

Form 4
$886.4K
bought · 3 insiders
$0
sold · 0 insiders
+10.1%
vs their $76.08 cost
DateInsiderTypeValue
Oct 30, 2026
Stetter Mark
Director
Oct 30, 2026
AWARD$466.49
Oct 9, 2026
Sarbaugh Keith
Executive Vice President
Oct 9, 2026
AWARD$7.9K
Oct 9, 2026
Driscoll Rimma
Executive Vice President
Oct 9, 2026
AWARD$7.3K
Oct 9, 2026
Nayak Abhay U
Executive Vice President
Oct 9, 2026
AWARD$8.4K
Oct 9, 2026
Lagano Roxanne
Executive Vice President
Oct 9, 2026
AWARD$9.6K
Oct 9, 2026
Ferran Astorga Jeannette
Executive Vice President
Oct 9, 2026
AWARD$1.4K
Oct 9, 2026
FULLER JULIE
Executive Vice President
Oct 9, 2026
AWARD$9.6K
Oct 9, 2026
PECK KRISTIN C
Chief Executive Officer
Oct 9, 2026
AWARD$18.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 5, 2026 SEC
Zoetis Q3 2026 revenue of $2.391B was slightly above the $2.30B consensus, but GAAP net income fell 18% YoY to $591M…
8-K · Impact 5/10
Nov 5, 2026 Earnings result
ZTS Q3 2026 Earnings: EPS $1.75 (+14.6% vs est)
Oct 30, 2026 Insider
Stetter Mark was granted 5.852 shares
Director @ $79.72 ($466.49)
Oct 21, 2026 Congress
Shelley Moore Capito sell
$1,001 - $15,000 · Senate
Oct 16, 2026 SEC
Three asset managers accumulated $10.0M in Zoetis shares during Q3 2026, led by Wealth Enhancement Advisory Services…
INST-CLUSTER · Impact 4/10
Oct 13, 2026 SEC
Zoetis appointed Iris Knobloch to its Board of Directors, effective December 1, 2026, increasing board size from 12 to…
8-K · Impact 2/10
Oct 13, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 · House
Oct 9, 2026 Insider
Sarbaugh Keith was granted 303.49 shares
Executive Vice President @ $26.17 ($7.9K)

Short side

FINRA· Oct 30, 2026
16,722,420
shares short
-4.5%
vs prior settlement
4.8
days to cover
≈4.1%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
5 drugs tracked · Drug pipeline →
Recent
Nov 5, 2026
Earnings result
ZTS Q3 2026 Earnings: EPS $1.75 (+14.6% vs est)
Aug 14, 2026
Short interest
Short Interest: ZTS down 21% to 16.8M shares
Settlement 2026-08-14 | Days to cover: 1.95 | ≈4.06% of shares outstanding (est.)
Aug 6, 2026
Earnings date
ZTS Q2 2026 Earnings Before Market Open, 2026-08-06
Jul 24, 2026
Press release
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, July 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the…
Jul 23, 2026
Press release
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS
NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the…
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 4 3 in posts · 1 in comments
Recent posts
Recent comments
All social signals and their track records

Washington

Corporate Lobbying

25 lobbying filings and 1 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

10 filings · 1 bullish · 4 bearish · 5 neutral
All ZTS filing & press-release reports (10)